353 related articles for article (PubMed ID: 12970646)
1. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia.
Clericuzio CL; Chen E; McNeil DE; O'Connor T; Zackai EH; Medne L; Tomlinson G; DeBaun M
J Pediatr; 2003 Aug; 143(2):270-2. PubMed ID: 12970646
[TBL] [Abstract][Full Text] [Related]
2. Hepatoblastoma associated with Beckwith-Wiedemann syndrome and hemihypertrophy.
Hamada Y; Takada K; Fukunaga S; Hioki K
Pediatr Surg Int; 2003 Apr; 19(1-2):112-4. PubMed ID: 12721741
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein (AFP) levels in normal children.
Ohama K; Nagase H; Ogino K; Tsuchida K; Tanaka M; Kubo M; Horita S; Kawakami K; Ohmori M
Eur J Pediatr Surg; 1997 Oct; 7(5):267-9. PubMed ID: 9402482
[TBL] [Abstract][Full Text] [Related]
4. Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice.
Tan TY; Amor DJ
J Paediatr Child Health; 2006 Sep; 42(9):486-90. PubMed ID: 16925531
[TBL] [Abstract][Full Text] [Related]
5. Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome.
Everman DB; Shuman C; Dzolganovski B; O'riordan MA; Weksberg R; Robin NH
J Pediatr; 2000 Jul; 137(1):123-7. PubMed ID: 10891834
[TBL] [Abstract][Full Text] [Related]
6. α-Fetoprotein assay on dried blood spot for hepatoblastoma screening in children with overgrowth-cancer predisposition syndromes.
Mussa A; Pagliardini S; Pagliardini V; Molinatto C; Baldassarre G; Corrias A; Silengo MC; Ferrero GB
Pediatr Res; 2014 Dec; 76(6):544-8. PubMed ID: 25167201
[TBL] [Abstract][Full Text] [Related]
7. Pancreatoblastoma associated with incomplete Beckwith-Wiedemann syndrome: case report and review of the literature.
Muguerza R; Rodriguez A; Formigo E; Montero M; Vázquez JL; Páramo C; Campos C
J Pediatr Surg; 2005 Aug; 40(8):1341-4. PubMed ID: 16080945
[TBL] [Abstract][Full Text] [Related]
8. The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome.
Duffy KA; Deardorff MA; Kalish JM
Am J Med Genet A; 2017 Mar; 173(3):581-584. PubMed ID: 28160403
[TBL] [Abstract][Full Text] [Related]
9. Defining an optimal time window to screen for hepatoblastoma in children with Beckwith-Wiedemann syndrome.
Mussa A; Duffy KA; Carli D; Ferrero GB; Kalish JM
Pediatr Blood Cancer; 2019 Jan; 66(1):e27492. PubMed ID: 30270492
[TBL] [Abstract][Full Text] [Related]
10. Congenital Hepatoblastoma and Beckwith-Wiedemann Syndrome.
Zivot A; Edelman M; Glick R; Hong A; Fish JD
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e798-e800. PubMed ID: 31335825
[TBL] [Abstract][Full Text] [Related]
11. Early presentation of right adrenal mass, hepatoblastoma and hepatic cavernous haemangioma in Beckwith-Wiedemann Syndrome.
Teh SH; Ong GB
Med J Malaysia; 2007 Oct; 62(4):345-6. PubMed ID: 18551945
[TBL] [Abstract][Full Text] [Related]
12. Serum alpha-fetoprotein screening for hepatoblastoma in Beckwith-Wiedemann syndrome.
Mussa A; Ferrero GB
Am J Med Genet A; 2017 Mar; 173(3):585-587. PubMed ID: 28211991
[No Abstract] [Full Text] [Related]
13. Neonatal hepatoblastoma in a newborn with severe phenotype of Beckwith-Wiedemann syndrome.
Mussa A; Ferrero GB; Ceoloni B; Basso E; Chiesa N; De Crescenzo A; Pepe E; Silengo M; de Sanctis L
Eur J Pediatr; 2011 Nov; 170(11):1407-11. PubMed ID: 21448630
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal hamartoma of the liver associated with features of Beckwith-Wiedemann syndrome and high serum alpha-fetoprotein levels.
Cajaiba MM; Sarita-Reyes C; Zambrano E; Reyes-Múgica M
Pediatr Dev Pathol; 2007; 10(3):233-8. PubMed ID: 17535089
[TBL] [Abstract][Full Text] [Related]
15. DLK1, a serum marker for hepatoblastoma in young infants.
Falix FA; Aronson DC; Lamers WH; Hiralall JK; Seppen J
Pediatr Blood Cancer; 2012 Oct; 59(4):743-5. PubMed ID: 22180200
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith-Wiedemann syndrome with high dose acetaminophen and N-acetylcysteine rescue.
Kobrinsky NL; Sjolander DE; Goldenberg JA; Ortmeier TC
Pediatr Blood Cancer; 2005 Aug; 45(2):222-5. PubMed ID: 15770640
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia.
Clericuzio CL; Martin RA
Genet Med; 2009 Mar; 11(3):220-2. PubMed ID: 19367194
[TBL] [Abstract][Full Text] [Related]
18. Development of the Serum α-Fetoprotein Reference Range in Patients with Beckwith-Wiedemann Spectrum.
Duffy KA; Cohen JL; Elci OU; Kalish JM
J Pediatr; 2019 Sep; 212():195-200.e2. PubMed ID: 31235384
[TBL] [Abstract][Full Text] [Related]
19. Favorable outcome in children with Beckwith-Wiedemann syndrome and intraabdominal malignant tumors.
Vaughan WG; Sanders DW; Grosfeld JL; Plumley DA; Rescorla FJ; Scherer LR; West KW; Breitfeld PP
J Pediatr Surg; 1995 Jul; 30(7):1042-4; discussion 1044-5. PubMed ID: 7472929
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT for Molecular Imaging of Hepatoblastoma in Beckwith-Wiedemann Syndrome.
Derlin T; Hartung D; Hueper K
Clin Nucl Med; 2018 May; 43(5):e164-e165. PubMed ID: 29485435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
